Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis
Emmanuel Kwateng Drokow,1 Hafiz Abdul Waqas Ahmed,1 Cecilia Amponsem-Boateng,2 Gloria Selorm Akpabla,3 Juanjuan Song,1 Mingyue Shi,1 Kai Sun11Department of Hematology, Zhengzhou University People‘s Hospital & Henan Provincial People‘s Hospital Henan, Zhengzhou, People&...
Guardado en:
Autores principales: | Drokow EK, Ahmed HAW, Amponsem-Boateng C, Akpabla GS, Song J, Shi M, Sun K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a5c552a7f454c9fb414c61d736147d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
T Cell Fitness and Autologous CAR T Cell Therapy in Haematologic Malignancy
por: Palak H. Mehta, et al.
Publicado: (2021) -
Spectrum of Haematological malignancies managed at tertiary centre: A one-year retrospective review
por: Anjan Shrestha, et al.
Publicado: (2018) -
PARP Inhibitors and Haematological Malignancies—Friend or Foe?
por: Kathryn A. Skelding, et al.
Publicado: (2021) -
Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
por: Sara Small, et al.
Publicado: (2021) -
Cytokine Expression of Lung Bacterial Infection in Newly Diagnosed Adult Hematological Malignancies
por: Zengzheng Li, et al.
Publicado: (2021)